Actively Recruiting
Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)
Led by Yale University · Updated on 2026-01-29
135
Participants Needed
3
Research Sites
129 weeks
Total Duration
On this page
Sponsors
Y
Yale University
Lead Sponsor
N
National Institute of Mental Health (NIMH)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts and PWID regarding their experiences with ART. This strategy will then be pilot tested in a randomized controlled trial (Aim 3). The research will not impact the type of medication and dose prescribed, but rather, how soon providers are able to prescribe ART after diagnosis. The focus of this registration is Aim 3.
CONDITIONS
Official Title
Reducing Stigma in People Who Inject Drugs (PWID) With HIV Using a Rapid Start Antiretroviral Therapy Intervention (ART)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be a person who injects drugs (PWID) from the general population enrolling into ART services at one of the study's HIV clinics, including those injecting opioids, amphetamines, or other injectable drugs. Some may have Opioid Use Disorder (OUD).
- Provide informed consent.
- HIV clinicians must prescribe ART for a PWID in one of the selected clinics.
- HIV clinicians must be willing to use the RS-ART protocol.
- HIV clinicians must be at least 18 years old.
- PWID enrolling into ART services at Kajang prison, including those injecting opioids, amphetamines, or other injectable drugs. Some may have Opioid Use Disorder (OUD).
- Provide informed consent.
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Kajang Prison
Kajang, Malaysia, 43000
Actively Recruiting
2
Centre of Excellence for Research in AIDS (CERiA) - University of Malaya
Kuala Lumpur, Malaysia, 50450
Active, Not Recruiting
3
Primary Healthcare Centers
Kuala Lumpur, Malaysia, 50450
Actively Recruiting
Research Team
D
David Oliveros Gómez, MPH
CONTACT
D
Daniel J Bromberg, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here